A deal that was months in the making is finally official, with Aetna's board of directors approving on Sunday the health insurer’s sale to drugstore chain operator CVS Health Corp for approximately $207 per share in cash and stock, in a deal worth $67 billion, multiple news sources reported on Sunday afternoon. The purchase price represents a premium of 29% to where Aetna shares were trading before the WSJ first reported that the two companies were in talks in October.
Submitted by Shant Movsesian and Rajan Dhall MSTA fxdailyterminal.com
Authored by David Stockman via Contra Corner blog,
In the past few days two Federal Reserve presidents have discussed cryptocurrencies and concluded they are "niche" and "don't matter today."
The longest short-squeeze streak in history continues...
Unless the world comes to a very serious end overnight, global equity markets are about to do something they have never done before... rise for 13 consecutive months.